HOME >> MEDICINE >> NEWS
Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice

that require blood vessels in order to grow. These agents are also being investigated in studies of humans who have a type of sight-robbing macular degeneration associated with the proliferation of abnormal new blood vessels in the eye.

While angiogenesis inhibitors are being used in cancer and vision research studies, heart disease investigations are focusing on angiogenesis promoters. In the heart research, scientists are testing in humans certain genes and their protein products that promote angiogenesis. The goal of this research is to circumvent coronary arteries obstructed by the plaque deposits that characterize atherosclerosis, the disease process that causes heart disease.

Very tiny blood vessels called capillaries can grow from the artery wall and invade plaque. Whether these vessels promote plaque growth is uncertain. The Circulation paper provides the "most persuasive evidence to date" that these new blood vessels are a prerequisite for plaque expansion, says Jeffrey M. Isner, M.D., in an editorial accompanying the paper. Isner is chief of vascular medicine and cardiovascular research, department of medicine, St. Elizabeth's Medical Center, Boston, and professor of medicine and pathology, Tufts Medical School, Boston.

Does this evidence suggest that gene and protein treatments designed to promote angiogenesis in people with heart disease could result in the development of larger plaque in these individuals?

Recent human and animal studies on angiogenesis and heart disease have not revealed plaque growth as a result of these treatments, says Isner, one of several scientists conducting this type of research.

The mice in this experiment were fed a "Western diet," which is designed to mimic the cholesterol content of the typical diet eaten in the United States. The amount of plaque the mice developed was measured in the aorta, the large artery that carries blood from the heart to the rest of
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
5-Apr-1999


Page: 1 2 3 4

Related medicine news :

1. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
2. Growth factor grows stem cells that help heal hearts
3. Growth hormone, sex steroid combination not ready for prime time
4. New Technique Induces Growth Across Spinal Cord Injury
5. Growth-Hormone Deficient Babies Are Normal Length At Birth, UB Study Finds
6. New Chemicals Could Lead To First Bone Growth Pill
7. Novel Biological Interaction Found To Explain Blood Vessel Growth To Tumors
8. Common Dental Bleaching Ingredient May Promote Growth Of Precancerous Oral Lesions, UB Dental Researchers Find
9. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
10. National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children
11. Health Workers May Experience Costly Dislocation As Health Spending Growth Slows

Post Your Comments:
(Date:8/20/2014)... Taking the widely used antibiotic clarithromycin may boost ... new study suggests. Because millions of people receive ... said the Danish researchers behind the study. However, they ... guidelines for the use of the drug should not ... heart expert wasn,t surprised by the finding, however. ...
(Date:8/20/2014)... According to a new market research report ... Crystal, Microblinds, Thermographic and Photochromics), by application (Architectural, ... geography - Global Forecast to 2014 - 2020", ... market was worth $1581.4 Million in 2013, and ... at an estimated CAGR of 20% from 2014 ...
(Date:8/20/2014)... Washington, D.C. (PRWEB) August 20, 2014 ... has received a five-year, $1.24 million Science Education ... of Health to support NAHN’s collaborative project with ... Models in Health Careers. , This collaborative NIH ... need for cultural and linguistic diversity among health ...
(Date:8/20/2014)... The report “Automotive Airbag and Seat Belt Market ... Geography - Trends and Forecasts 2014 - 2019”, ... and seatbelt market in terms of volume and ... the coming years as well as covers review ... challenges, legislation trends, market dynamics, competitive landscape, and ...
(Date:8/20/2014)... Oxnard dentist and noted international ... Art Institute, is presenting at the Spectrum Day Vancouver ... on All-on-4 dental implants in a presentation ... at 12:40 p.m. Sept. 20 at the Empire Landmark ... , “The All-on-4 procedure gives patients a set of ...
Breaking Medicine News(10 mins):Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 2Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 3Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 4Health News:Smart Glass Market by Technology Worth $5814 Million by 2020 – New Report by MarketsandMarkets 5Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3
(Date:8/20/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), ... that its VENTANA System for Primary Diagnosis 1 ... Union for routine pathology, including primary diagnosis with ... Virtuoso software coupled with either the VENTANA iScan ... provides automated digital slide creation, case management and ...
(Date:8/20/2014)... BURLINGTON, Mass. , Aug. 20, 2014 ... Japanese electrophysiology (EP) mapping and ablation device ... increasingly use ablation to treat atrial fibrillation ... a primary treatment option for AF will ... for this application, such as advanced loop ...
(Date:8/20/2014)... 2014  Amerigen Pharmaceuticals Ltd. announces that its ... received Chinese FDA (CFDA) approval and has subsequently ... the China domestic market.  ... agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., Amerigen ... approved and China CFDA certified oral solid dose ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2
Cached News: